Yinci Zhang
Huainan, 232000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Coal Dust-Mimetic Carbon Nanoparticles Induce Colonic Epithelial Cell Senescence via p16/p21 Dual Pathways and Promote Colonic Inflammatory Response.
Journal: Journal of gastroenterology and hepatology
Published: January 05, 2026
Coal Dust Nanoparticles Induce Colitis-Like Lesions in Rats via Gut Microbiota Dysbiosis and P53/SCO2/SLC7A11-Mediated Epithelial Ferroptosis.
Journal: Digestive diseases and sciences
Published: November 20, 2025
From the Gut to the Mind: Elucidating the Microbiome-chronobiology Axis in the Context of Depressive Illness.
Journal: Current neuropharmacology
Published: August 31, 2025
Metformin attenuates coal dust nanoparticle-induced pulmonary fibrosis by modulating inflammation and epithelial-mesenchymal transition.
Journal: International immunopharmacology
Published: May 22, 2025
Occupational nanoparticles: major sources, physicochemical properties, multi-organ toxic effects, and associated mechanisms.
Journal: Toxicology mechanisms and methods
Published: May 21, 2025
Redefinition of Synovial Fibroblasts in Rheumatoid Arthritis.
Journal: Aging and disease
Published: April 30, 2024
Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Journal: The clinical respiratory journal
Published: April 27, 2023
Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals.
Journal: Cell death discovery
Published: July 11, 2022
The effects of coal dust exposure on DNA damage and repair of human bronchial epithelial cells.
Journal: Toxicology and industrial health
Published: May 28, 2022
Autophagy up-regulated by MEK/ERK promotes the repair of DNA damage caused by aflatoxin B1.
Journal: Toxicology mechanisms and methods
Published: August 16, 2021
Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells.
Journal: Translational cancer research
Published: March 10, 2020
Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells.
Journal: Journal of cancer research and clinical oncology
Published: February 23, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026